| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
12,250 |
11,370 |
$1.98M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,126 |
7,455 |
$1.35M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,813 |
1,708 |
$959K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,228 |
2,084 |
$750K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,364 |
2,232 |
$182K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,092 |
1,039 |
$178K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
317 |
296 |
$104K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
263 |
247 |
$50K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
90 |
85 |
$27K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
15 |
15 |
$10K |
| 72131 |
|
27 |
27 |
$9K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
3,187 |
2,824 |
$3K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,981 |
2,889 |
$1K |
| 93971 |
|
27 |
26 |
$1K |
| 73030 |
|
72 |
70 |
$863.04 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
422 |
332 |
$793.11 |
| 80053 |
Comprehensive metabolic panel |
6,326 |
5,778 |
$749.47 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,467 |
7,625 |
$740.92 |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,258 |
3,884 |
$717.93 |
| 81025 |
|
3,439 |
3,188 |
$564.87 |
| 93976 |
|
218 |
207 |
$413.09 |
| 73130 |
|
219 |
202 |
$410.76 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,059 |
1,933 |
$358.00 |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,885 |
2,653 |
$356.88 |
| 84484 |
|
3,148 |
2,821 |
$243.62 |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
37 |
37 |
$201.39 |
| 81003 |
|
6,544 |
6,033 |
$180.22 |
| 82803 |
|
1,947 |
1,783 |
$168.17 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
405 |
386 |
$150.93 |
| 36415 |
Collection of venous blood by venipuncture |
8,191 |
7,411 |
$149.71 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
489 |
464 |
$149.47 |
| 71045 |
Radiologic examination, chest; single view |
3,535 |
3,312 |
$146.82 |
| 71046 |
Radiologic examination, chest; 2 views |
1,703 |
1,618 |
$142.84 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,663 |
2,495 |
$100.00 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
3,394 |
3,160 |
$66.44 |
| 83880 |
|
611 |
565 |
$60.30 |
| 73110 |
|
69 |
65 |
$58.65 |
| 73610 |
|
296 |
284 |
$58.65 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
697 |
594 |
$52.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
296 |
281 |
$51.31 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,411 |
1,369 |
$44.15 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,678 |
2,423 |
$30.81 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
862 |
826 |
$26.00 |
| 73630 |
|
439 |
406 |
$24.22 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
4,100 |
3,696 |
$23.83 |
| 83605 |
|
1,985 |
1,804 |
$18.82 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
83 |
81 |
$13.09 |
| 80076 |
|
1,350 |
1,254 |
$12.76 |
| 80051 |
|
2,091 |
1,935 |
$12.46 |
| 82962 |
|
219 |
200 |
$7.23 |
| 73562 |
|
338 |
315 |
$0.00 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
301 |
289 |
$0.00 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
12 |
12 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,010 |
900 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
358 |
335 |
$0.00 |
| 80305 |
|
193 |
187 |
$0.00 |
| 90715 |
|
85 |
82 |
$0.00 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
63 |
60 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
27 |
24 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
12 |
12 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
26 |
20 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
407 |
388 |
$0.00 |
| J3490 |
Unclassified drugs |
1,413 |
1,232 |
$0.00 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
133 |
116 |
$0.00 |
| 87040 |
|
438 |
413 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
775 |
743 |
$0.00 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
206 |
165 |
$0.00 |
| 87077 |
|
38 |
37 |
$0.00 |
| 76801 |
|
13 |
13 |
$0.00 |
| 96361 |
Intravenous infusion, hydration; each additional hour |
929 |
885 |
$0.00 |
| 96376 |
|
115 |
107 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
32 |
26 |
$0.00 |
| 83690 |
|
57 |
56 |
$0.00 |